Mounjaro (tirzepatide), a newer dual GIP/GLP-1 receptor agonist, has shown comparable hair loss patterns in clinical trials, with approximately 5-6% of participants reporting alopecia as a side effect during periods of drastic weight loss [3]
Along with mitochondria, synapses are considered end effectors of many molecular mechanisms related to ASD, and the convergence of different neurodevelopmental pathological mechanisms on synapses can at least partially explain the behavioral similarities in different individuals on the spectrum
The medication binds to GLP-1 receptors throughout the body, and those receptors exist in far more places than the gut
Chemoprotection against n-Methyl-N-Nitro-N-Nitrosoguanidine-Induced oxidative stress by s-allylcysteine, a garlic constituent, in wistar rats
It is briefly mentioned in the Drug Interactions section to say the drug delays gastric emptying, and may impact absorption of concomitantly administered oral medications. It is also briefly mentioned in the Pharmacodynamics section, which describes how the drug works
The shorter needle length reaches subcutaneous tissue without risk of intramuscular injection, and the finer gauge reduces injection site discomfort